Dr Anne E Roberge, | |
101 Columbian St, Weymouth, MA 02190 | |
(781) 624-5000 | |
(781) 624-4840 |
Full Name | Dr Anne E Roberge |
---|---|
Gender | Female |
Speciality | Hematology/oncology |
Experience | 35 Years |
Location | 101 Columbian St, Weymouth, Massachusetts |
Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
Identifier | Type | State | Issuer |
---|---|---|---|
1639115041 | NPI | - | NPPES |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
207RH0003X | Internal Medicine - Hematology & Oncology | 81605 (Massachusetts) | Primary |
Facility Name | Location | Facility Type |
---|---|---|
South Shore Hospital | South weymouth, MA | Hospital |
Brigham And Women's Hospital | Boston, MA | Hospital |
Group Practice Name | Group PECOS PAC ID | No. of Members |
---|---|---|
Dana-farber Cancer Institute, Inc. | 9133038904 | 538 |
News Archive
A high-fidelity simulator that allows people to practice driving on a computer-generated course can help stroke patients learn to drive again, researchers have found.
Packing a lunchbox with fruit, sandwiches, and snacks is common practice for most Australian families. But what if there was another way?
Roche NimbleGen announced today that Taipei-based genomic services provider Gene Biodesign Enterprises Co. has officially joined the Roche NimbleGen Certified Service Provider (CSP) Program.
The recently discovered retrovirus, xenotropic murine leukemia virus-related virus (XMRV), has been identified in some prostate cancer patients. In light of conflicting data concerning XMRV, standardized diagnostic testing is important to identify patients in which XMRV is present and to determine whether it plays a role in the incidence of prostate cancer.
› Verified 8 days ago
Entity Name | Dana-farber Cancer Institute, Inc. |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1346433257 PECOS PAC ID: 9133038904 Enrollment ID: O20040223000142 |
News Archive
A high-fidelity simulator that allows people to practice driving on a computer-generated course can help stroke patients learn to drive again, researchers have found.
Packing a lunchbox with fruit, sandwiches, and snacks is common practice for most Australian families. But what if there was another way?
Roche NimbleGen announced today that Taipei-based genomic services provider Gene Biodesign Enterprises Co. has officially joined the Roche NimbleGen Certified Service Provider (CSP) Program.
The recently discovered retrovirus, xenotropic murine leukemia virus-related virus (XMRV), has been identified in some prostate cancer patients. In light of conflicting data concerning XMRV, standardized diagnostic testing is important to identify patients in which XMRV is present and to determine whether it plays a role in the incidence of prostate cancer.
› Verified 8 days ago
Entity Name | Dana-farber Cancer Institute, Inc. |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1851333686 PECOS PAC ID: 9133038904 Enrollment ID: O20040223000228 |
News Archive
A high-fidelity simulator that allows people to practice driving on a computer-generated course can help stroke patients learn to drive again, researchers have found.
Packing a lunchbox with fruit, sandwiches, and snacks is common practice for most Australian families. But what if there was another way?
Roche NimbleGen announced today that Taipei-based genomic services provider Gene Biodesign Enterprises Co. has officially joined the Roche NimbleGen Certified Service Provider (CSP) Program.
The recently discovered retrovirus, xenotropic murine leukemia virus-related virus (XMRV), has been identified in some prostate cancer patients. In light of conflicting data concerning XMRV, standardized diagnostic testing is important to identify patients in which XMRV is present and to determine whether it plays a role in the incidence of prostate cancer.
› Verified 8 days ago
Entity Name | Coastal Medical Associates |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1932175684 PECOS PAC ID: 7113029257 Enrollment ID: O20070221000057 |
News Archive
A high-fidelity simulator that allows people to practice driving on a computer-generated course can help stroke patients learn to drive again, researchers have found.
Packing a lunchbox with fruit, sandwiches, and snacks is common practice for most Australian families. But what if there was another way?
Roche NimbleGen announced today that Taipei-based genomic services provider Gene Biodesign Enterprises Co. has officially joined the Roche NimbleGen Certified Service Provider (CSP) Program.
The recently discovered retrovirus, xenotropic murine leukemia virus-related virus (XMRV), has been identified in some prostate cancer patients. In light of conflicting data concerning XMRV, standardized diagnostic testing is important to identify patients in which XMRV is present and to determine whether it plays a role in the incidence of prostate cancer.
› Verified 8 days ago
Mailing Address | Practice Location Address |
---|---|
Dr Anne E Roberge, 101 Columbian St, Weymouth, MA 02190-1601 Ph: (781) 624-5000 | Dr Anne E Roberge, 101 Columbian St, Weymouth, MA 02190 Ph: (781) 624-5000 |
News Archive
A high-fidelity simulator that allows people to practice driving on a computer-generated course can help stroke patients learn to drive again, researchers have found.
Packing a lunchbox with fruit, sandwiches, and snacks is common practice for most Australian families. But what if there was another way?
Roche NimbleGen announced today that Taipei-based genomic services provider Gene Biodesign Enterprises Co. has officially joined the Roche NimbleGen Certified Service Provider (CSP) Program.
The recently discovered retrovirus, xenotropic murine leukemia virus-related virus (XMRV), has been identified in some prostate cancer patients. In light of conflicting data concerning XMRV, standardized diagnostic testing is important to identify patients in which XMRV is present and to determine whether it plays a role in the incidence of prostate cancer.
› Verified 8 days ago
Todd Alan Kerensky, M.D. Hematology & Oncology Medicare: Accepting Medicare Assignments Practice Location: 55 Fogg Road, Weymouth, MA 02190 Phone: 781-624-8000 Fax: 781-878-6750 | |
Ronald W Dunlap, M.D. Hematology & Oncology Medicare: Not Enrolled in Medicare Practice Location: 70 Pleasant St, South Shore Cardiology, Weymouth, MA 02190 Phone: 781-331-2000 | |
Dr. Sveta Shah Oza, M.D. Hematology & Oncology Medicare: Accepting Medicare Assignments Practice Location: 90 Libbey Pkwy, Weymouth, MA 02189 Phone: 781-331-2922 Fax: 781-682-0611 | |
Dr. Matthew D Giangola, M.D. Hematology & Oncology Medicare: Accepting Medicare Assignments Practice Location: 55 Fogg Road, Weymouth, MA 02190 Phone: 781-792-4136 Fax: 781-878-6750 | |
Leonid D Shturman, D.O. Hematology & Oncology Medicare: Accepting Medicare Assignments Practice Location: 90 Libbey Industrial Pkwy, Weymouth, MA 02189 Phone: 781-682-0610 Fax: 781-682-0611 | |
Vitaly E Ermolin, MD Hematology & Oncology Medicare: Accepting Medicare Assignments Practice Location: 55 Fogg Rd, Weymouth, MA 02190 Phone: 781-624-8000 Fax: 781-878-6750 | |
Michael J Anderson, M.D. Hematology & Oncology Medicare: Medicare Enrolled Practice Location: 51 Performance Dr, Suite 110, Weymouth, MA 02189 Phone: 781-340-0735 Fax: 781-331-6355 |